News

Phase 3 IFT Study results presented at AAN 2024 show that IV fosphenytoin provides fast, significant pain relief for acute trigeminal neuralgia exacerbations, with good tolerability.
A large U.S. registry study of ide-cel CAR-T therapy in relapsed/refractory multiple myeloma shows strong response rates and a safety profile comparable to clinical trials—even among older and ...
A new endoscopic method using a long transparent cap offers a faster, safe, and effective approach to gastrointestinal defect ...
Marama Labs' CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and ...
PERCUTANEOUS coronary intervention (PCI) for unprotected left main coronary artery (ULMCA) disease demonstrates favourable ...
Discover how a recent meta-analysis showed VEIL improves perioperative outcomes compared to OIL in penile cancer treatment.
A LIVE-attenuated herpes zoster vaccine may help reduce the risk of developing dementia, according to a new study that used a ...
Discover the study that shows a new PRS spit test is more effective than the current UK prostate cancer screening pathway.
Discover the future of radiology in EMJ’s latest issue, which explores how radiology can become more sustainable, the rapid evolution ...
New study has demonstrated that using MRI-based radiomic features with clinical data improves the prediction of disease ...
THE SMART-CP model has shown to significantly improve access to early diagnosis and rehabilitation services for children with ...
New research reveals that symptom patterns in infants under 1 year—especially wheezing, eczema, and GI issues—may predict ...